Methyl-DOB

Methyl-DOB
Clinical data
Other namesN-Methyl-DOB; 4-Bromo-2,5-dimethoxy-N-methylamphetamine
Routes of
administration		Oral[1]
Drug classPsychoactive drug
ATC code
  • None
Pharmacokinetic data
Duration of action"Probably rather long"[1]
Identifiers
  • 1-(4-bromo-2,5-dimethoxyphenyl)-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H18BrNO2
Molar mass288.185 g·mol−1
3D model (JSmol)
  • Brc1cc(OC)c(cc1OC)CC(NC)C
  • InChI=1S/C12H18BrNO2/c1-8(14-2)5-9-6-12(16-4)10(13)7-11(9)15-3/h6-8,14H,5H2,1-4H3 checkY
  • Key:GURVSGCCXMIFMQ-UHFFFAOYSA-N checkY
  (verify)

Methyl-DOB, or N-methyl-DOB, also known as 4-bromo-2,5-dimethoxy-N-methylamphetamine, is a psychoactive drug.[1] It is similar in structure to DOB.[1] In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists methyl-DOB's minimum dose as 8 mg and its duration as "probably rather long".[1] Methyl-DOB produces many physical effects, such as mydriasis and muscle tenseness, but few psychoactive effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Methyl-DOB.[1] Methyl-DOB was first described in the literature by Shulgin in PiHKAL in 1991.[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[2]

See also

References

  1. ^ a b c d e f g h Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  2. ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.